As a whole, PD patients carrying GBA1 variants are characterized by a more severe clinical phenotype compared with patients negative for variants in GBA1 and LRRK2 (hereinafter, referred to as sporadic PD, sPD) [7, 8]. This evidence concerns the gene GBA1 and Parkinson disease.